Development of a sensitive bioanalytical method for the quantification of lacosamide in rat plasma. Application to preclinical pharmacokinetics studies in rats

Arzneimittelforschung. 2012 May;62(5):243-6. doi: 10.1055/s-0032-1301911. Epub 2012 Mar 1.

Abstract

A sensitive and selective high performance liquid chromatographic (HPLC) method was developed and validated for quantification of lacosamide in rat plasma. A liquid-liquid extraction procedure was optimized to extract lacosamide from rat plasma. Chromatographic separation was accomplished using a reversed phase C18 Hichrom (250×4.6 mm, 5 µm) column with the mobile phase consisting of acetonitrile-phosphate buffer (pH 3.2±0.1; 20 mM) (21:79, v/v) at a flow rate of 1 mL/min. Both intra- and inter day assay precision and accuracy were lower than 15% CV. The lower limit of quantitation was 25 ng/mL for lacosamide and the response was linear in a concentration range from 25 to 10 000 ng/mL. The developed method was successfully used for the preclinical pharmacokinetic study of lacosamide in rats.

MeSH terms

  • Acetamides / blood*
  • Acetamides / pharmacokinetics
  • Animals
  • Anticonvulsants / blood*
  • Anticonvulsants / pharmacokinetics
  • Calibration
  • Chromatography, High Pressure Liquid
  • Hydrogen-Ion Concentration
  • Indicators and Reagents
  • Lacosamide
  • Liquid-Liquid Extraction
  • Rats
  • Rats, Wistar
  • Reference Standards
  • Reproducibility of Results
  • Solvents
  • Spectrophotometry, Ultraviolet

Substances

  • Acetamides
  • Anticonvulsants
  • Indicators and Reagents
  • Solvents
  • Lacosamide